To further define the impact of CD4+ T cell immunity on breast cancer cells, we compared the transcriptome of advanced breast tumors from Tslp-PyMttg Rag1KO + CD4+ T cell (test) and PyMttg Rag1KO + CD4+ T cell (control) groups. Here, TSLP is linked to breast neoplasm.